We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

250 hedge funds and large institutions have $465M invested in Editas Medicine in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 64 increasing their positions, 68 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $10.8M

8.38% more ownership

Funds ownership: 70.22% → 78.6% (+8.4%)

6% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 68

5% less funds holding

Funds holding: 264 → 250 (-14)

21% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 53

21% less capital invested

Capital invested by funds: $591M → $465M (-$126M)

Holders
250
Holders Change
-14
Holders Change %
-5.3%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
64
Reduced
68
Closed
53
Calls
$15.7M
Puts
$10.8M
Net Calls
+$4.89M
Net Calls Change
-$232K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$31.5M
2
WP
Woodline Partners
California
+$22.8M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$10.9M
4
Bank of America
Bank of America
North Carolina
+$4.42M
5
BlackRock
BlackRock
New York
+$3.91M

Top Sellers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
-$4.61M
2
NAMA
Nikko Asset Management Americas
New York
-$4.36M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$4.36M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.06M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$3.25M – – –
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$3.07M +$2.86M +260,737 +306%
Citigroup
28
Citigroup
New York
$3.07M -$898K -81,816 -19%
EP
29
Edgestream Partners
New Jersey
$2.65M +$923K +84,098 +39%
Mirae Asset Global Investments
30
Mirae Asset Global Investments
South Korea
$2.57M -$693K -63,137 -18%
SOMRS
31
State of Michigan Retirement System
Michigan
$2.43M – – –
Wells Fargo
32
Wells Fargo
California
$2.41M +$905K +82,438 +43%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$2.34M +$823K +74,959 +40%
Deutsche Bank
34
Deutsche Bank
Germany
$2.31M +$2.03M +184,682 +243%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.28M +$38.4K +3,494 +1%
PAMS
36
Pictet Asset Management (Switzerland)
Switzerland
$2.21M +$730K +66,485 +36%
LOAMS
37
Lombard Odier Asset Management (Switzerland)
Switzerland
$2.15M – – –
SFI
38
Susquehanna Fundamental Investments
Pennsylvania
$1.73M +$2.15M +195,502 New
Ameriprise
39
Ameriprise
Minnesota
$1.72M -$68.9K -6,275 -3%
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.47M +$47.2K +4,300 +3%
Legal & General Group
41
Legal & General Group
United Kingdom
$1.38M +$1.03M +93,750 +153%
LCM
42
Laurion Capital Management
New York
$1.24M -$7.23K -659 -0.5%
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$1.23M +$128K +11,677 +9%
SCM
44
Shelton Capital Management
Colorado
$1.2M -$112K -10,200 -7%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$992K -$3.06M -278,921 -71%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$989K +$31.6K +2,881 +3%
Axa
47
Axa
France
$987K +$1.22M +111,300 New
PP
48
PDT Partners
New York
$972K -$166K -15,158 -12%
Jane Street
49
Jane Street
New York
$951K -$167K -15,244 -12%
JFG
50
Jefferies Financial Group
New York
$924K +$1.14M +104,223 New
1
2
3 4 5

EDIT Hedge Fund Activity: Q4 2022 in Review

250 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2022, worth a combined $465M — down 21% from $591M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of EDIT and 42 opened new positions — a net loss of 11 holders — while 68 trimmed existing stakes and 64 added.

The largest buyer was State Street, adding an estimated $31.5M. The largest seller was Cubist Systematic Strategies, exiting entirely with an estimated $4.61M sold.

  • 250 institutional investors held Editas Medicine (EDIT) as of Q4 2022, down from 264 in Q3 2022.
  • Funds reported $465M of Editas Medicine stock for Q4 2022, down 21% quarter-over-quarter.
  • 42 funds opened new Editas Medicine positions in Q4 2022 and 53 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q4 2022 was State Street, an estimated $31.5M added.
  • The largest Editas Medicine seller in Q4 2022 was Cubist Systematic Strategies, an estimated $4.61M sold.

Based on aggregated 13F filings for Q4 2022.